Judge won't allow AFT Pharmaceuticals to submit more evidence in Pascomer dispute

Judge won't allow AFT Pharmaceuticals to submit more evidence in Pascomer dispute
AFT Pharmaceuticals' Hartley Atkinson. (Image: AFT)
Riley Kennedy
A bid to offer up more evidence by AFT Pharmaceuticals, after the three-week trial with PBL Solutions over the drug Pascomer, has been rejected by the high court. The case relates to the long-running dispute between the two over a joint subsidiary they were part of for the purpose of developing and commercialising orphan drugs (those used to treat rare diseases).The relationship broke down, with AFT claiming it had the rights to the topical treatment Pascomer, whereas PBL argued the subsidiary did.PBL filed its claim in June 2020, accusing...

More Law & Regulation

FNZ case adds plaintiffs in latest legal twist
Finance

FNZ case adds plaintiffs in latest legal twist

Employee shareholders at FNZ are using a second entity.

ANZ heads to court as select committee splits active litigation
Finance

ANZ heads to court as select committee splits active litigation

ANZ NZ consumer-finance case rumbles on as $300m settlement still on offer.

Andy Macdonald 21 Oct 2025
RBNZ and the curious case of prudential stacks
Opinion

Andy Macdonald: RBNZ and the curious case of prudential stacks

The end result of the RBNZ’s capital review will be both revealing and fascinating.

Andy Macdonald 21 Oct 2025
Solar projects face rising delays from consents
Law & Regulation

Solar projects face rising delays from consents

Survey finds solar consents are harder, wind a bit easier.

Ian Llewellyn 21 Oct 2025